Biem’s out-licensing activities are built on its strong manufacturing infrastructure, high quality standards, and vision to bring its product portfolio to international markets.
Portfolio Priorities
High market-potential products
Formulations aligned with international regulatory requirements
Opportunities across strategic therapeutic segments
70
Country
93
Licenses Received
Biem Worldwide
Portfolio of Products
Licensed Products
High-potential products in the market.
CTD Dosier Ready Products
Licensible full dosier content.
Pipeline Products
R&D portfolio, reformulations or new technologies.
Business Models
License Agreements
Transfer of commercial rights for specific countries.
Technology Transfer
Sharing of manufacturing know-how and quality processes.
Shared R&D Projects
Development of new formulations or product variants.
Why Biem?
International Quality Standards
Compliance with GMP, ISO, and similar standards.
Strong Manufacturing Capability
Advanced manufacturing capacity through Biem’s production facility in Çerkezköy, Tekirdağ.
Transparent and Flexible Collaboration Approach
Project-by-project evaluation based on mutual benefit.
